Evidence map›Paper›PMID 42563564›Full record

ArticleMolecular oncology2026

RETRACTION: LncRNA AATBC Regulates Pinin to Promote Metastasis in Nasopharyngeal Carcinoma.

Abstract readRetraction Notice
In one paragraph

Article in Molecular oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

retractionT. Tang, L. Yang, Y. Cao, M. Wang, S. Zhang, Z. Gong, F. Xiong, Y. He, Y. Zhou, Q. Liao, B. Xiang, M. Zhou, C. Guo, X. Li, Y. Li, W. Xiong, G. Li, and Z. Zeng, "LncRNA AATBC Regulates Pinin to Promote Metastasis in Nasopharyngeal Carcinoma," Molecular Oncology 14, no. 9 (2020): 2251-2270, https://doi.org/10.1002/1878-0261.12703. The above article, published online on 4 May 2020 in Wiley Online Library (https://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor-in-Chief, Kevin M. Ryan; the Federation of European Biochemical Societies; and John Wiley & Sons Ltd. The retraction has been agreed due to concerns raised by third parties. Specifically, image elements in Figures 2D and 2G were found to have been previously published by the author group in different scientific contexts. Furthermore, the GAPDH blots derived from the CNE2 cells for the "NC" and "siPNN" groups in Figure 4B, and for the "NC" and "1237-3p" groups in Figure 5C were found duplicated. In addition, overlapping regions were identified between the panels depicting the "NC" and "siAATBC + PNN" groups within the CNE2 lane. While the authors acknowledged the errors and supplied raw data in support of their response, the editors deemed the clarification insufficient to address their concerns. The authors attributed the mistakes to similarities between the affected images, raising concerns over the accuracy of the data presented in the remaining body of the article. Furthermore, further review determined that the vast majority of the cited references were self-citations, many of which were found to be irrelevant or only marginally relevant to the context at hand, resulting in several statements lacking adequate support from the literature. Accordingly, the article has been retracted, as the editors have lost confidence in the reliability of the results and conclusions presented. The authors have been informed of the retraction decision, but were not available for final confirmation.

Identifiers

PMID42563564
PMCPMC13448557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.